MedTrace Logo

PACTAID App in Adults With Type 1 Diabetes to Help Manage Exercise

NCT06730906 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-05-18

No results posted yet for this study

Summary

The purpose of this trial is to test and refine the PACTAID smart phone application in adults with type 1 diabetes mellitus to help manage exercise while on automated insulin delivery systems with the goal of improving glycemic control during and after exercise as well as improving multiple other cardiovascular risk factors.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

DEVICE

PACTAID App

The PACTAID app will provide real time decision support during exercise for patients with type 1 diabetes.

Sponsors & Collaborators

  • Arizona State University

    collaborator OTHER

  • University of Houston

    collaborator OTHER

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Yogish Kudva · Mayo Clinic

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-10
Primary Completion
2026-12-28
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06730906 on ClinicalTrials.gov